Author

V. Kairisto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

E. Loyttyniemi· 1 shared E. Makela· 1 shared J. Westermarck· 1 shared M. Itala-Remes· 1 shared O. Kauko· 1 shared T. Varila· 1 shared U. Salmenniemi· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. Loyttyniemi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ARPP19 promotes MYC expression and associates with patient relapse in acute myeloid leukemia

E. Makela, E. Loyttyniemi, U. Salmenniemi, O. Kauko, T. Varila, V. Kairisto, M. Itala-Remes, J. Westermarck

This study identifies ARPP19 as an oncogenic PP2A inhibitor in AML that predicts relapse independently of risk classification and is associated with disease activity.

bioRxiv · Jul 5, 2019Cancer Biology